In addition, although many drugs targeting oncogenic kinases have been used for the treatment of cancers, only a few drugs targeting PTPs (e.g., PTP1B, SHP2, CDC25, and PRLs) are under clinical trials [204]. Here, PTPN11 is linked to cancer.